CRIS Current Research Information System

PASQUALI, RENATO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.001
AS - Asia 8.701
EU - Europa 7.941
SA - Sud America 714
AF - Africa 491
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 9
Totale 30.872
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.846
SG - Singapore 2.373
GB - Regno Unito 2.370
VN - Vietnam 2.264
CN - Cina 2.184
IT - Italia 1.122
DE - Germania 947
SE - Svezia 891
FR - Francia 602
HK - Hong Kong 596
BR - Brasile 549
RU - Federazione Russa 483
UA - Ucraina 470
IN - India 454
IE - Irlanda 283
ZA - Sudafrica 214
BD - Bangladesh 177
JP - Giappone 163
EE - Estonia 162
FI - Finlandia 120
CH - Svizzera 116
TG - Togo 108
NL - Olanda 91
KR - Corea 89
CA - Canada 71
BG - Bulgaria 67
AR - Argentina 66
CI - Costa d'Avorio 59
PH - Filippine 55
BE - Belgio 50
IQ - Iraq 43
MX - Messico 40
SC - Seychelles 36
JO - Giordania 34
AT - Austria 32
ID - Indonesia 32
EC - Ecuador 31
TH - Thailandia 31
TR - Turchia 28
GR - Grecia 26
PK - Pakistan 25
IR - Iran 24
NG - Nigeria 23
PL - Polonia 23
SA - Arabia Saudita 21
ES - Italia 20
TW - Taiwan 20
CL - Cile 19
UZ - Uzbekistan 19
PY - Paraguay 17
LB - Libano 14
AU - Australia 12
MY - Malesia 12
RO - Romania 12
EG - Egitto 11
HN - Honduras 11
MA - Marocco 11
CO - Colombia 10
PE - Perù 10
PT - Portogallo 9
CZ - Repubblica Ceca 8
KZ - Kazakistan 8
VE - Venezuela 8
HR - Croazia 7
JM - Giamaica 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
ET - Etiopia 6
EU - Europa 6
LT - Lituania 6
TN - Tunisia 6
BZ - Belize 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
MD - Moldavia 4
SN - Senegal 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
CY - Cipro 3
DZ - Algeria 3
GE - Georgia 3
IL - Israele 3
KW - Kuwait 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PA - Panama 3
RS - Serbia 3
SV - El Salvador 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BF - Burkina Faso 2
LV - Lettonia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
Totale 30.850
Salva come PNG Salva come JPEG
Città #
Southend 2.131
Ashburn 1.610
Singapore 1.529
Fairfield 1.492
Woodbridge 711
Wilmington 679
Seattle 665
Chandler 660
San Jose 607
Houston 604
Hong Kong 568
Cambridge 473
Santa Clara 452
Princeton 415
Dong Ket 410
Ho Chi Minh City 410
Ann Arbor 373
Hanoi 349
Jacksonville 307
Beijing 285
Dublin 281
Boardman 253
Bologna 238
Lauterbourg 214
Nanjing 200
Westminster 194
Padova 181
Hefei 167
Los Angeles 156
Tokyo 148
New York 123
Berlin 122
Buffalo 117
Lomé 108
Council Bluffs 107
Shenyang 106
Saint Petersburg 100
Helsinki 98
Jinan 97
Bern 92
San Diego 92
Haiphong 69
Dallas 67
Seoul 66
Sofia 66
São Paulo 66
Guangzhou 64
Nanchang 64
Milan 62
Changsha 61
Mülheim 61
Redondo Beach 60
Abidjan 59
Hebei 57
Da Nang 55
Tianjin 54
Shanghai 49
Bremen 46
Chicago 42
Turin 42
Redwood City 39
The Dalles 39
Brussels 38
Falls Church 37
Rome 36
Dearborn 34
Frankfurt am Main 34
Jiaxing 34
Norwalk 34
Olalla 34
Medford 33
Phoenix 33
Amman 32
Hangzhou 32
Zhengzhou 32
Orem 31
Redmond 31
Yubileyny 30
Munich 29
Can Tho 28
Des Moines 27
San Francisco 26
Johannesburg 25
Mahé 25
Haikou 23
Abeokuta 22
Naples 22
Florence 21
Taizhou 21
London 20
Ningbo 20
Taiyuan 20
Toronto 20
Verona 20
Vienna 20
Xi'an 20
Baghdad 19
Ha Long 19
San Venanzo 19
Lanzhou 18
Totale 20.131
Salva come PNG Salva come JPEG
Nome #
Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society 572
Predictors of weight loss and maintenance in patients treated with antiobesity drugs. 509
Defining hyperandrogenism in women with polycystic ovary syndrome: A challenging perspective 305
Centenarians’ offspring as a model of healthy aging: a reappraisal of the data on Italian subjects and a comprehensive overview 274
Behavioral, socio-environmental, educational and demographic correlates of excess body weight in Italian adolescents and young adults 264
CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. 254
Can imaging predict subclinical cortisol secretion in patients with adrenal adenomas? A CT predictive score 250
Heterogeneity of thyroid function and impact of peripheral thyroxine deiodination in centenarians and semi-supercentenarians: association with functional status and mortality. 250
Insulin sensitizers in polycystic ovary syndrome 246
Clomiphene citrate effect in obese men with low serum testosterone treated with metformin due to dysmetabolic disorders: A randomized, double-blind, placebo-controlled study 240
Il sistema endocannabinoide e il controllo del metabolismo energetico: fisiologia e fisiopatologia 239
Active and total ghrelin concentrations in the newborn 238
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. 236
Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone 232
Body mass index-independent metabolic alterations in narcolepsy with cataplexy. 231
Aldosterone and type 2 diabetes mellitus 231
17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome. 230
Acyl ghrelin and metabolic hormones in pregnant and lactating sows. 229
Androgen Profiling by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) in Healthy Normal-Weight Ovulatory and Anovulatory Late Adolescent and Young Women 224
Acute severe male hypo-testosteronemia affects central motor command in humans 224
Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women 224
The potential role of increased adrenal volume in the pathophysiology of obesity-related type 2 diabetes. 223
Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism 223
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma 221
Combined Aldosterone and Cortisol Secretion by Adrenal Incidentaloma 219
11C-meta-hydroxyephedrine PET/CT imaging allows in vivo study of adaptive thermogenesis and white-to-brown fat conversion 218
New insights on diabetes in Turner syndrome: results from an observational study in adulthood 217
A combination of polymorphisms in HSD11B1 associates with in vivo 11{beta}-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome. 216
Dietary habits and their relationship with hormones and metabolism in overweight and obese women with polycystic ovary syndrome 215
The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk 214
A comprehensive approach in diagnosing the polycystic ovary syndrome 209
Endocrine dysfunction in hereditary hemochromatosis 202
A new interaction to come: Ghrelin and steroid hormones 195
A placebo controlled, randomized clinical trial using testosterone undecanoate with injectable norethisterone enanthate: effects on anthropometric, metabolic and biochemical parameters 193
Anti-müllerian hormone and insulin-like 3 levels in healthy normal-weight ovulatory and anovulatory eumenorrheic late adolescent females: potential early biomarkers of ovarian dysfunction? 191
Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. 189
Salivary cortisol and cortisone responses to short-term psychological stress challenge in late adolescent and young women with different hyperandrogenic states 189
Cortisol, energy intake, and food frequency in overweight/obese women 188
Cross-talk between adipose tissue and the HPA axis in obesity and overt hypercortisolemic states 187
Psychological aspects of hyperandrogenic states in late adolescent and young women. 186
Short-term modification of sex hormones is associated with changes in ghrelin circulating levels in healthy normal-weight men. 185
The empowerment of translational research: lessons from laminopathies. 184
The negative association between total ghrelin levels, body mass and insulin secretion is lost in hypercortisolemic patients with Cushing's disease. 183
Effect of clomiphene citrate treatment on the Sertoli cells of dysmetabolic obese men with low testosterone levels 183
Clinical assessment of allostatic overload in adolescent and young women with hyperandrogenic states 182
Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome. 181
Circulating endocannabinoids are differentially modulated during the oral glucose tolerance test 181
Tablet and oral liquid L-thyroxine formulation in the treatment of naive hypothyroid patients with Helicobacter pylori infection 181
Cannabinoid type 1 receptor: another arrow in the adipocytes' bow 178
The endocannabinoid system and the treatment of obesity. 177
Obesity-related proliferative diseases: The interaction between adipose tissue and estrogens in post-menopausal women 177
Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes 173
The Significance of Low Testosterone Levels in Obese Men 173
Relationships between total and regional adiposity and epicardial fat in obese women: how can dual-energy X-ray absorptiometry be associated with echocardiographic epicardial fat measurements? 172
Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study. 172
Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome. 171
Energy balance regulation by endocannabinoids at central and peripheral levels 169
Serum steroid profiling by isotopic dilution-liquid chromatography-mass spectrometry: comparison with current immunoassays and reference intervals in healthy adults. 169
Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis. 168
In vivo dissolution of levothyroxine soft gel capsules 168
Fighting obesity and associated risk factors by antagonising cannabinoid type 1 receptors. 166
Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome. 166
EFFECT OF FASTING AND REFEEDING ON PLASMA GHRELIN LEVELS IN PREPUBERTAL GILTS 166
Improving the diagnosis of 11β-hydroxylase deficiency using home-made MLPA probes: identification of a novel chimeric CYP11B2/CYP11B1 gene in a Sicilian patient 165
Common variants in the sex hormone-binding globulin gene (SHBG) and polycystic ovary syndrome (PCOS) in Mediterranean women. 163
Adrenal adenomas, subclinical hypercortisolism, and cardiovascular outcomes 163
Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome. 163
Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 in overweight/obese women with polycystic ovary syndrome compared with weight-matched controls 162
Increased clearance of cortisol by 5beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome. 162
Monogenic polycystic ovary syndrome due to a mutation in the lamin A/C gene is sensitive to thiazolidinediones but not to metformin 161
Abdominal adiposity by ultrasonography: a "pocket" database for reference standard in Italian people 161
Le aree cerebrali ed i neurotrasmettitori deputati al senso di sazietà, piacere e dipendenza: quale ruolo nel mantenimento dell'obesità? 160
La surrenectomia laparoscopica: le dimensioni della lesione costituiscono un limite all'approccio mini-invasivo? 159
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 159
Plasma adiponectin in non alcoholic fatty liver disease is related to hepatic fat content and hepatic insulin resistance, not to liver disease severity 158
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline 157
Circulating obestatin levels and the grelin/obestatin ratio in obese women 157
Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. 156
Role of sex hormones in modulation of brown adipose tissue activity 156
Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study. 156
Hirsutism and virilization 155
Stress-related development of obesity and cortisol in women 155
No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours 155
Radiological formula for differentiating between secreting and non secreting adrenal adenomas. 154
Familial partial lipodystrophy, mandibuloacral dysplasia and restrictive dermopathy feature barrier-to-autointegration factor (BAF) nuclear redistribution 154
Obesity, fat distribution and infertility. 153
Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases. 153
Cannabinoid receptor antagonists and the metabolic syndrome: Novel promising therapeutical approaches. 153
Metabolic effects of obesity on reproduction. 151
Revisiting hyper- and hypo-androgenism by tandem mass spectrometry. 151
Prescription medications for the treatment of obesity 151
Basal insulin-like factor 3 levels predict functional ovarian hyperandrogenism in the polycystic ovary syndrome. 149
Formula radiologica per differenziare adenomi surrenalici secernenti e non secernenti 149
Obesity and androgens: facts and perspectives. 148
Sindrome dell'ovaio policistico e diabete di tipo 2 148
Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome. 148
Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern. 148
Metabolic alterations and cardiovascular risk factors in the polycystic ovary syndrome. 147
Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors 147
Human chorionic gonadotropin stimulation gives evidence of differences in testicular steroidogenesis in Klinefelter syndrome, as assessed by liquid chromatography-tandem mass spectrometry 146
Totale 19.355
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.581
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.581
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021880 0 0 0 0 0 0 0 0 0 0 0 880
2021/20223.732 386 148 250 307 320 204 94 249 123 249 831 571
2022/20233.381 421 477 168 478 182 209 102 170 542 217 248 167
2023/20241.362 101 167 64 44 63 164 256 359 20 57 43 24
2024/20253.414 134 695 336 226 675 200 205 72 41 133 81 616
2025/20268.507 585 723 797 677 964 565 875 308 1.597 635 467 314
Totale 31.302